Biotechnology

Ocimum Biosolutions Announces “The Great Exchange” - LIMS Swap Program

Ocimum Biosolutions Announces “The Great Exchange” - LIMS Swap Program
Hyderabad, Andhra Pradesh, India, and Gaithersburg, Maryland, United States, October 16, 2009: Ocimum Biosolutions today announced the launch of its new LIMS Swap Program, which will allow organizations that are currently using Data/Lab Information Management Systems (LIMS) that are no longer meeting their needs to trade-in these systems for its world-class Laboratory Information Management Solution, Biotracker™ LIMS. The solutions that can be exchanged through this program include COTS (Commercial ...

GVK Biosciences shortlisted for the European Outsourcing Awards 2009

GVK Biosciences shortlisted for the European Outsourcing Awards 2009
GVK Biosciences Private Limited (GVK BIO), Asia’s leading research services company has been shortlisted for two European Outsourcing Awards 2009. GVK BIO had filed its nominations under two categories “Best New Product” and the “Bes t New Partnership/ cquisition/Merger” GVK BIO’s entry for the “Best New Product” was its innovative “Clinical Biomarker Database” developed together with a Big Pharma and the US FDA “. “GVK BIO – Wyeth: Value co-creators” was GVK B ...

Athena Environmental Sciences, Inc. Receives A Phase-I SBIR Grant To Develop A Protein Expression and Purification Instrument

Baltimore, Maryland, September 26th, 2009-- Athena Enzyme Systems™, a division of Athena Environmental Sciences, Inc., provides products and services that help researchers and manufacturers improve the production and recovery of recombinant proteins. The company has recently been awarded a NSF Phase I SBIR grant to design and build a bench-top protein expression and purification instrument based on its licensed YebF technology. Athena Enzyme Systems™ (AthenaES®) is based in Baltimore, Maryland and ...

Nanomi joins consortium to address chronic kidney disease

Nanomi joins consortium to address chronic kidney disease June 28, 2009 - Oldenzaal, The Netherlands Nanomi, a leading provider of microsphere-based drug delivery technologies to the pharmaceutical industry, announced today that it joined a consortium for the development of a therapy to prevent chronic kidney disease. In an aging population, the worldwide incidence of chronic kidney disease, requiring dialysis ...
Syndicate content